REPORT ID 6825

Global Meningococcal Conjugate Vaccine Market Size, Status and Forecast 2022

Publish Date
1-Nov-17
Pages
94
Format
Electronic (PDF)

This report studies the global Meningococcal Conjugate Vaccine market, analyzes and researches the Meningococcal Conjugate Vaccine development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Sanofi Pasteur
    Pfizer
    GlaxoSmithKline
    Hualan Biological Engineering
    JN International Medical Corporation
    Baxter International
    Merck
    Serum Institute of India
    Biomed
    Novartis

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Meningococcal Conjugate Vaccine can be split into
    Mono Vaccines
    Combination Vaccines

Market segment by Application, Meningococcal Conjugate Vaccine can be split into
    Children
    Preteens or Teens
    Adults

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Meningococcal Conjugate Vaccine Market Size, Status and Forecast 2022
1 Industry Overview of Meningococcal Conjugate Vaccine
    1.1  Meningococcal Conjugate Vaccine Market Overview
        1.1.1 Meningococcal Conjugate Vaccine Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Meningococcal Conjugate Vaccine Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Meningococcal Conjugate Vaccine Market by Type
        1.3.1 Mono Vaccines
        1.3.2 Combination Vaccines
    1.4 Meningococcal Conjugate Vaccine Market by End Users/Application
        1.4.1 Children
        1.4.2 Preteens or Teens
        1.4.3 Adults

2 Global Meningococcal Conjugate Vaccine Competition Analysis by Players
    2.1 Meningococcal Conjugate Vaccine Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Sanofi Pasteur
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Pfizer
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 GlaxoSmithKline
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Hualan Biological Engineering
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 JN International Medical Corporation
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Baxter International
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Merck
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Serum Institute of India
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Biomed
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Novartis
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
        3.10.5 Recent Developments

4 Global Meningococcal Conjugate Vaccine Market Size by Type and Application (2012-2017)
    4.1 Global Meningococcal Conjugate Vaccine Market Size by Type (2012-2017)
    4.2 Global Meningococcal Conjugate Vaccine Market Size by Application (2012-2017)
    4.3 Potential Application of Meningococcal Conjugate Vaccine in Future
    4.4 Top Consumer/End Users of Meningococcal Conjugate Vaccine

5 United States Meningococcal Conjugate Vaccine Development Status and Outlook
    5.1 United States Meningococcal Conjugate Vaccine Market Size (2012-2017)
    5.2 United States Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

6 EU Meningococcal Conjugate Vaccine Development Status and Outlook
    6.1 EU Meningococcal Conjugate Vaccine Market Size (2012-2017)
    6.2 EU Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

7 Japan Meningococcal Conjugate Vaccine Development Status and Outlook
    7.1 Japan Meningococcal Conjugate Vaccine Market Size (2012-2017)
    7.2 Japan Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

8 China Meningococcal Conjugate Vaccine Development Status and Outlook
    8.1 China Meningococcal Conjugate Vaccine Market Size (2012-2017)
    8.2 China Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

9 India Meningococcal Conjugate Vaccine Development Status and Outlook
    9.1 India Meningococcal Conjugate Vaccine Market Size (2012-2017)
    9.2 India Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Meningococcal Conjugate Vaccine Development Status and Outlook
    10.1 Southeast Asia Meningococcal Conjugate Vaccine Market Size (2012-2017)
    10.2 Southeast Asia Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Meningococcal Conjugate Vaccine Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
        11.1.2 EU Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
        11.1.4 China Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
        11.1.5 India Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
    11.2 Global Meningococcal Conjugate Vaccine Market Size (Value) by Type (2017-2022)
    11.3 Global Meningococcal Conjugate Vaccine Market Size by Application (2017-2022)

12 Meningococcal Conjugate Vaccine Market Dynamics
    12.1 Meningococcal Conjugate Vaccine Market Opportunities
    12.2 Meningococcal Conjugate Vaccine Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Meningococcal Conjugate Vaccine Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Meningococcal Conjugate Vaccine Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source